We manage synovial sarcoma as a deceptive malignancy that often presents in young adults after years of dormancy. Under the clinical direction of Dr. Saminathan Suresh Nathan, we focus on the specific genotype nuances (SYT-SSX) that dictate prognosis. Unlike most soft tissue sarcomas, we maintain high vigilance for lymphatic spread, utilizing specialized surveillance techniques to ensure systemic control alongside radical local resection.
Sentinel Lymph Node Biopsy: Employing nodal surveillance for synovial sarcoma, which has a higher propensity for lymphatic metastasis than other soft tissue subtypes.
Joint-Adjacent Dissection: Specialized techniques for resecting tumors near joint capsules without violating the joint space, preserving articular function.
Long-Term Monitoring: Given the "slow-growing" nature often reported by patients, we enforce a strict 10-year surveillance window to catch late local or systemic failures.